Your Input: | |||||
CYP1A2 | Cytochrome P450 1A5; Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. (530 aa) | ||||
ANGPTL4 | Angiopoietin like 4. (478 aa) | ||||
STAT5A | Signal transducer and activator of transcription. (764 aa) | ||||
CYP3A4 | Uncharacterized protein; Belongs to the cytochrome P450 family. (540 aa) | ||||
TXNIP | Thioredoxin interacting protein. (430 aa) | ||||
SIRT1 | Deacetylase sirtuin-type domain-containing protein. (881 aa) | ||||
PPARD | Uncharacterized protein. (545 aa) | ||||
NR1H3 | Uncharacterized protein. (519 aa) | ||||
ADIPOQ | C1q domain-containing protein. (244 aa) | ||||
PCSK9 | Proprotein convertase subtilisin/kexin type 9; Belongs to the peptidase S8 family. (643 aa) | ||||
PNPLA3 | Patatin like phospholipase domain containing 3. (543 aa) | ||||
PPARG | Peroxisome proliferator-activated receptor gamma; Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut ho [...] (498 aa) | ||||
SLCO1B3 | Solute carrier organic anion transporter family member. (722 aa) | ||||
HNF1A | Hepatocyte nuclear factor 1-alpha; Transcriptional activator that regulates the tissue specific expression of multiple genes, especially in pancreatic islet cells and in liver. May participate in the control of the hormone-dependent expression of the lysozyme gene in the oviduct and liver. In liver it could repress the gene while in oviduct it may act as an activator. Belongs to the HNF1 homeobox family. (634 aa) | ||||
STAT4 | Signal transducer and activator of transcription. (749 aa) | ||||
CYP7A1 | Cholesterol 7-alpha-monooxygenase; Belongs to the cytochrome P450 family. (513 aa) | ||||
STAT2 | Signal transducer and activator of transcription. (961 aa) | ||||
RXRA | Retinoid X receptor alpha. (467 aa) | ||||
STAT1 | Signal transducer and activator of transcription. (755 aa) | ||||
NFKBIA | NF-kappa-B inhibitor alpha; Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. May be involved in regulation of transcriptional responses to NF-kappa-B, including cell adhesion, immune and proinflammatory responses, apoptosis, differentiation and growth. Controlled by sequential serine-phosphorylation, ubiquitination and degradation. Tyrosine-phosphorylation could only lead to dissociation from NF-kappa- B (By similarity). (318 aa) | ||||
HMOX1 | Heme oxygenase 1; Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. (317 aa) | ||||
GCLC | Glutamate-cysteine ligase catalytic subunit. (636 aa) | ||||
ABCG1 | ATP binding cassette subfamily G member 1. (666 aa) | ||||
ABCA1 | Uncharacterized protein. (2260 aa) | ||||
NR1H4 | Farnesoid X receptor. (473 aa) | ||||
INS | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. (107 aa) |